Evidence map›Paper›PMID 23993337›Full record

ArticleBlood cells, molecules & diseases2014

Iron deficiency modifies gene expression variation induced by augmented hypoxia sensing.

Xu Zhang, Wei Zhang, Shwu-Fan Ma, Galina Miasniakova, Adelina Sergueeva, Tatiana Ammosova, Min Xu, Sergei Nekhai, Mehdi Nourai, Michael S Wade and 4 more

Abstract read
In one paragraph

Article in Blood cells, molecules & diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Iron, oxygen, and the pulmonary circulation.Journal of applied physiology (Bethesda, Md. : 1985) · 2015
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Xu ZhangComprehensive Sickle Cell Center, Section of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Wei ZhangDepartment of Pediatrics, University of Illinois at Chicago, Chicago, IL, USA.
Shwu-Fan MaSection of Pulmonary/Critical Care, Department of Medicine, University of Chicago, Chicago, IL, USA.
Galina MiasniakovaChuvash Republic Clinical Hospital 2, Cheboksary, Russian Federation, Howard University, Washington, DC.
Adelina SergueevaCheboksary Children's Hospital, Cheboksary, Russian Federation, Howard University, Washington, DC.
Tatiana AmmosovaCenter for Sickle Cell Disease, Howard University, Washington, DC.
Min XuCenter for Sickle Cell Disease, Howard University, Washington, DC.
Sergei NekhaiCenter for Sickle Cell Disease, Howard University, Washington, DC.
Mehdi NouraiCenter for Sickle Cell Disease, Howard University, Washington, DC.
Michael S WadeSection of Pulmonary, Critical Care & Sleep Medicine, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Josef T PrchalDepartments of Medicine, Pathology and Genetics, University of Utah and VAH.
Joe G N Garcia *Section of Pulmonary, Critical Care & Sleep Medicine, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Roberto F Machado *Section of Pulmonary, Critical Care & Sleep Medicine, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Victor R Gordeuk *Comprehensive Sickle Cell Center, Section of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
University of Illinois Chicago · USHoward University · USChuvash State University · RUUniversity of Chicago · USUniversity of Utah · US

Funding

Tissue BankP01CA108671 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Ronald Hoffman · 2006 to 2026
$82.0M
STRUCTURAL/FUNCTIONAL CHARACTERIZATION OF AMINOGLYCOSIDEG12RR003048 · NCRR · HOWARD UNIVERSITY · PI SOUTHERLAND, WILLIAM M. · 1985 to 2011
$19.0M
UVDM01RR010284 · NCRR · HOWARD UNIVERSITY · PI TAYLOR, WILLIAM ROBERT · 1996 to 2010
$17.4M
PROTEOMICS CORE FACILITYG12MD007597 · NIMHD · HOWARD UNIVERSITY · PI SOUTHERLAND, WILLIAM M. · 2012 to 2018
$14.8M
Vascular Targeting Genomic & Genetic Strategies for Acute Chest SyndromeR01HL111656 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI Roberto F. Machado · 2013 to 2026
$7.9M
Pulmonary Hypertension and the Hypoxic Response in SCDR01HL079912 · NHLBI · HOWARD UNIVERSITY · PI GORDEUK, VICTOR R · 2005 to 2008
$7.4M
Center for Hemoglobin Research in Minorities (CHaRM)P50HL118006 · NHLBI · HOWARD UNIVERSITY · PI NEKHAI, SERGEI · 2013 to 2017
$7.0M
Sickle Cell Disease and Sickle Cell Trait Protection Against HIV-1-infection in Africans and African AmericansR01HL125005 · NHLBI · HOWARD UNIVERSITY · PI MARINA A JEREBTSOVA, SERGEI NEKHAI · 2014 to 2026
$6.7M
Labile Iron Pools In Hempglobin S ErythmocytesUH1HL003679 · NHLBI · HOWARD UNIVERSITY · PI GORDEUK, VICTOR R · 1996 to 2004
$3.5M
Howard University Research Scientist AwardR25HL003679 · NHLBI · HOWARD UNIVERSITY · PI NEKHAI, SERGEI · 2005 to 2009
$1.7M
Regulation of HIV-1 Transcription by CDK2SC1GM082325 · NIGMS · HOWARD UNIVERSITY · PI NEKHAI, SERGEI · 2008 to 2011
$1.2M
Carbon monoxide therapy for severe pulmonary arterial hypertensionK23HL098454 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MACHADO, ROBERTO F. · 2010 to 2014
$657k
NCI NIH HHS P01 CA108671NCI NIH HHS P01CA108671NCRR NIH HHS 2G12RR003048NCRR NIH HHS G12 RR003048NCRR NIH HHS M01 RR010284NHLBI NIH HHS 1P30HL107253NHLBI NIH HHS 2 R25-HL03679-08NHLBI NIH HHS K23 HL098454NHLBI NIH HHS K23HL098454NHLBI NIH HHS P30 HL107253NHLBI NIH HHS P50 HL118006NHLBI NIH HHS R01 HL079912NHLBI NIH HHS R01 HL079912-04NHLBI NIH HHS R01 HL111656NHLBI NIH HHS R01HL111656NHLBI NIH HHS R01 HL125005NHLBI NIH HHS R25 HL003679NHLBI NIH HHS UH1 HL003679NIGMS NIH HHS SC1 GM082325NIGMS NIH HHS SC1GM082325NIMHD NIH HHS 8G12MD007597NIMHD NIH HHS G12 MD007597OCPHP CDC HHS MO1-PR10284
6 · The paper itself

Abstract

In congenital Chuvash polycythemia (CP), VHL(R200W) homozygosity leads to elevated hypoxia inducible factor (HIF) levels at normoxia. CP is often treated by phlebotomy resulting in iron deficiency, permitting us to examine the separate and synergistic effects of iron deficiency and HIF signaling on gene expression. We compared peripheral blood mononuclear cell gene expression profiles of eight VHL(R200W) homozygotes with 17 wildtype individuals with normal iron status and found 812 up-regulated and 2120 down-regulated genes at false discovery rate of 0.05. Among differential genes we identified three major gene regulation modules involving induction of innate immune responses, alteration of carbohydrate and lipid metabolism, and down-regulation of cell proliferation, stress-induced apoptosis and T-cell activation. These observations suggest molecular mechanisms for previous observations in CP of lower blood sugar without increased insulin and low oncogenic potential. Studies including 16 additional VHL(R200W) homozygotes with low ferritin indicated that iron deficiency enhanced the induction effect of VHL(R200W) for 50 genes including hemoglobin synthesis loci but suppressed the effect for 107 genes enriched for HIF-2 targets. This pattern is consistent with potentiation of HIF-1α protein stability by iron deficiency but a trend for down-regulation of HIF-2α translation by iron deficiency overriding an increase in HIF-2α protein stability.

Indexed as

Anemia, Iron-DeficiencyBasic Helix-Loop-Helix ProteinsBlood GlucoseEndothelial PAS Domain-Containing Protein 1Gene Expression RegulationHomozygoteHumansHypoxiaHypoxia-Inducible Factor 1, alpha SubunitImmunity, InnateInsulinIronLeukocytes, MononuclearPhlebotomyPolycythemiaProtein StabilityBasic Helix-Loop-Helix ProteinsBlood GlucoseEndothelial PAS Domain-Containing Protein 1HIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitInsulinIronVHL protein, humanVon Hippel-Lindau Tumor Suppressor ProteinChuvash polycythemiaGene expressionHypoxia inducible factorHypoxia-sensingIron deficiencyVHL

Identifiers

PMID23993337
PMCPMC3852195
OpenAlexW1998585658

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.